Defining the Next Decade of BioPharma Innovation and Excellence
At a time when the industry faces increasing pressure to strengthen manufacturing capability, accelerate innovation, enhance supply chain resilience and improve access to medicines, BioPharma Vietnam provides a forum for the global and regional leaders to engage in shaping what comes next.
The BioPharma Vietnam Summit is where pharmaceutical policy is shaped, investment decisions are validated and the strategic priorities defining Asia’s life sciences decade are set. Bringing together Ministers, sovereign investors, global pharmaceutical executives and scientific leaders, the Summit operates at the highest level of the industry - where what is decided in the room has consequences far beyond it.
Who Takes the Stage
Ministers and government policymakers setting Asia’s pharmaceutical industrial strategy. Global pharmaceutical CEOs making market entry and investment decisions.
Sovereign wealth and institutional investors committing capital to the region’s life sciences future. Regulatory leaders shaping the frameworks that determine how medicines reach patients across Asia.
Shape the Agenda
The Summit programme is built around the people with genuine authority, real capital and strategic foresight on Asia’s pharmaceutical future. Speaking opportunities are available across all seven conference themes.
Get Involved
Contact our team to discuss speaking, investment showcase or engagement opportunities.
Government Strategy & Pharmaceutical Sovereignty
How governments across Asia are accelerating industrial policy, reducing import dependency and building regulatory and investment frameworks that underpin pharmaceutical independence.
Pharmaceutical Manufacturing & Localisation
Scaling GMP-compliant domestic production, attracting foreign manufacturing investment and strengthening the supply chain alternatives reshaping Asia’s pharmaceutical infrastructure.
Biotech, Biologics & Advanced Therapies
Advancing the next generation of biologics, vaccines, biosimilars and cell and gene therapies from early innovation through to commercial scale across Asia’s life sciences markets
Life Sciences Investment & Market Access
Where sovereign capital, private equity and corporate investors converge with the regulatory pathways and market access strategies unlocking Asia’s pharmaceutical opportunity.
AI, Digital Innovation & Precision Medicine
How artificial intelligence, data-driven drug discovery and precision medicine are redefining pharmaceutical development and why Asia is positioned to lead that transformation.
Supply Chain Resilience & Distribution
Building the logistics networks, cold chain systems and distribution infrastructure that secure Asia’s pharmaceutical supply chains against single-source dependency.
Clinical Research & Commercialisation
Expanding Asia’s clinical trial capabilities, accelerating research infrastructure and forging partnerships that move innovation from discovery to patient access at scale.
